IHE ETF Holdings

Holdings

Symbol	Grade	Price % Change	Allocation
JNJ	D	0.17	22.46
LLY	F	-1.30	21.89
BMY	A	-2.60	4.93
VTRS	B	0.17	4.58
PFE	D	-0.74	4.37
ZTS	D	1.77	4.32
CTLT	D	0.22	4.24
MRK	F	-0.43	4.18
RPRX	D	0.37	4.17
ITCI	A	2.11	2.93
JAZZ	D	0.38	2.63
ELAN	D	-0.32	2.41
OGN	D	-3.78	1.75
CORT	B	-2.76	1.73
PBH	A	0.41	1.42
AXSM	C	-0.21	1.41
PRGO	D	1.79	1.35
LGND	A	4.11	0.80
EWTX	B	1.28	0.79
AMPH	A	0.40	0.74
SUPN	B	-0.29	0.73
ARVN	C	1.78	0.68
TARS	A	6.32	0.53
SAVA	D	1.57	0.48
AMRX	B	1.00	0.48
COLL	F	-1.99	0.44
NMRA	F	-2.45	0.43
INVA	C	-1.53	0.43
HRMY	D	2.96	0.40
ANIP	F	1.65	0.39
ELVN	B	-0.79	0.33
PCRX	C	-0.18	0.31
PLRX	A	3.20	0.29
PHAT	B	6.53	0.23
RVNC	C	-1.69	0.19
MNMD	C	-2.54	0.18
NUVB	F	4.07	0.15
TBPH	C	0.49	0.12

Represented by ETF Holdings

Keywords: Biopharmaceutical Pharmaceutical Products Pain Pharmaceutical Medicine S&P 500 Alzheimer's Disease Animal Health Drugs Biotechnology Depression Diabetes Drug Development Life Sciences Medication Neuroscience Pharmacology Antibiotics Cancer Depressive Disorder

Industries: Biotechnology Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major Drug Manufacturers - General Medical Distribution

Recent News for iShares U.S. Pharmaceutical ETF & its Holdings

Date	Stock	Title
Nov 2	ITCI	Here's What Analysts Are Forecasting For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) After Its Third-Quarter Results
Nov 1	LLY	Lilly to Present Results from Phase 3 EMBER-3 Study of Imlunestrant, an Oral SERD, and Additional Results from Its Breast Cancer Portfolio at the San Antonio Breast Cancer Symposium
Nov 1	LLY	Market Volatility Soars Ahead Of Elections, Tech Earnings Mixed, Strikes And Hurricanes Knock Employment Down: This Week In The Markets
Nov 1	LLY	Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
Nov 1	ZTS	Zoetis Q3 2024 Earnings Preview
Nov 1	JNJ	Stocks that hedge funds moved from long to short in August - Jefferies
Nov 1	BMY	Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
Nov 1	PFE	Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
Nov 1	LLY	Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
Nov 1	MRK	Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease
Nov 1	ZTS	Stocks to watch next week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
Nov 1	LLY	Stocks to watch next week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
Nov 1	CORT	Earnings Estimates Moving Higher for Corcept (CORT): Time to Buy?
Nov 1	HRMY	Earnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 1	OGN	Organon Third Quarter 2024 Earnings: EPS: US$1.39 (vs US$0.23 in 3Q 2023)
Nov 1	LLY	Hims & Hers Health Faces Pressure Ahead of Earnings Amid Eli Lilly's GLP-1 News
Nov 1	BMY	Bristol Myers posts long-term Phase 3 data for schizophrenia drug Cobenfy
Nov 1	PFE	3 Reasons Relying on Social Security Alone Could be a Risk. And 3 Stocks to Invest in Today.
Nov 1	ANIP	Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to Decline
Nov 1	ARVN	Arvinas Third Quarter 2024 Earnings: Beats Expectations

The investment seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index (the "underlying index"), which measures the performance of the pharmaceuticals sector of the U.S. equity market. The fund is non-diversified.
Exchange Traded Fund ETF

ETF Components for IHE - iShares U.S. Pharmaceutical ETF